Evidence map›Paper›PMID 33858378›Full record

ArticleBMC infectious diseases2021

Clinical metagenomics assessments improve diagnosis and outcomes in community-acquired pneumonia.

Fei Xie, Zhimei Duan, Weiqi Zeng, Shumei Xie, Mingzhou Xie, Han Fu, Qing Ye, Teng Xu, Lixin Xie

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 54 citations in OpenAlex.

  1. Microbiome Profiling Reveals Prognostic Heterogeneity inmedRxiv : the preprint server for health sciences · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
  9. The respiratory tract virome: unravelling the role of viral dark matter in respiratory health and disease.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Fei Xie *Chinese People's Liberation Army General Hospital, Beijing, 100039, China.
Zhimei Duan *Chinese People's Liberation Army General Hospital, Beijing, 100039, China.
Weiqi Zeng *Vision Medicals Center for Medical Research, Guangdong, China.
Shumei XieVision Medicals Center for Medical Research, Guangdong, China.
Mingzhou XieVision Medicals Center for Medical Research, Guangdong, China.
Han FuChinese People's Liberation Army General Hospital, Beijing, 100039, China.
Qing YeVision Medicals Center for Medical Research, Guangdong, China.
Teng XuVision Medicals Center for Medical Research, Guangdong, China. txu@visionmedicals.com.
Lixin XieChinese People's Liberation Army General Hospital, Beijing, 100039, China. xielx301@126.com.
Chinese People's Liberation Army · CNPeople's Liberation Army No. 150 Hospital · CNYunnan Animal Science and Veterinary Institute · CN

Funding

Key Program of Translational Medicine of PLA General Hospital 2018TM-03Military Medical Innovation Research Project of PLA General Hospital 2019YFC0121703National Natural Science Foundation of China 61976223
6 · The paper itself

Abstract

backgroundIdentifying the causes of community-acquired pneumonia (CAP) is challenging due to the disease's complex etiology and the limitations of traditional microbiological diagnostic methods. Recent advances in next generation sequencing (NGS)-based metagenomics allow pan-pathogen detection in a single assay, and may have significant advantages over culture-based techniques.

resultsWe conducted a cohort study of 159 CAP patients to assess the diagnostic performance of a clinical metagenomics assay and its impact on clinical management and patient outcomes. When compared to other techniques, clinical metagenomics detected more pathogens in more CAP cases, and identified a substantial number of polymicrobial infections. Moreover, metagenomics results led to changes in or confirmation of clinical management in 35 of 59 cases; these 35 cases also had significantly improved patient outcomes.

conclusionsClinical metagenomics could be a valuable tool for the diagnosis and treatment of CAP.

trial registrationTrial registration number with the Chinese Clinical Trial Registry: ChiCTR2100043628 .

Indexed as

AdultAgedAged, 80 and overBronchoalveolar Lavage FluidCohort StudiesCommunity-Acquired InfectionsDNA, BacterialFemaleHigh-Throughput Nucleotide SequencingHumansMaleMetagenomicsMiddle AgedMycobacterium tuberculosisPneumoniaSequence Analysis, DNADNA, BacterialClinical metagenomicsClinical studyCommunity-acquired pneumoniaNext-generation sequencingPolymicrobial infections

Identifiers

PMID33858378
PMCPMC8047593
OpenAlexW3154261266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.